The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TAS-118 (S-1 plus leucovorin) versus S-1 in gemcitabine-refractory advanced pancreatic cancer: A randomized, open-label, phase III trial (GRAPE trial).
 
Makoto Ueno
Honoraria - AstraZeneca; Lilly; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Eisai
Research Funding - AstraZeneca; Daiichi Sankyo; Eisai; Merck Serono; MSD; NanoCarrier; Ono Pharmaceutical; Shire; Taiho Pharmaceutical; Zeria Pharmaceutical
 
Tatsuya Ioka
Consulting or Advisory Role - AstraZeneca; Baxalta; Taiho Pharmaceutical; Yakult Honsha
Speakers' Bureau - Daiichi Sankyo; Eisai; Fujifilm; Taiho Pharmaceutical; Yakult Honsha
Research Funding - AstraZeneca; GlaxoSmithKline; Merck Serono; Nihon Zouki; Taiho Pharmaceutical; Zeria Pharmaceutical
 
Hideki Ueno
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Baxalta; Lilly; NanoCarrier; Taiho Pharmaceutical
 
Joon Oh Park
Honoraria - Celgene; Taiho Pharmaceutical
Consulting or Advisory Role - Celgene
Research Funding - AstraZeneca; Celgene; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Taiho Pharmaceutical
 
Heung-Moon Chang
Research Funding - Celgene; Novartis; Pharmacyclics; Taiho Pharmaceutical
 
Naoki Sasahira
Honoraria - Taiho Pharmaceutical
Research Funding - Eisai; Kyowa Hakko Kirin; Merck Serono; Taiho Pharmaceutical; Zeria Pharmaceutical
 
Masashi Kanai
Stock and Other Ownership Interests - Therabiopharma Inc.
Research Funding - Taiho Pharmaceutical
Patents, Royalties, Other Intellectual Property - Therabiopharma Inc.
 
Ik-Joo Chung
Research Funding - Taiho Pharmaceutical
 
Masafumi Ikeda
Honoraria - Abbott Japan; Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Eisai; Lilly Japan; Nippon Kayaku; Novartis; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer Yakuhin; Bristol-Myers Squibb; Eisai; Kyowa Hakko Kirin; Lilly Japan; NanoCarrier
Research Funding - ASLAN Pharmaceuticals; AstraZeneca; Baxter; Bayer Yakuhin; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Eisai; Kowa; Kowa; Kyowa Hakko Kirin; Lilly Japan; Merck Serono; NanoCarrier; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Pharmaceutical; Zeria Pharmaceutical
 
Shoji Nakamori
Research Funding - Eisai; Taiho Pharmaceutical
 
Nobumasa Mizuno
Honoraria - Kyowa Hakko Kirin; Novartis; Pfizer; Taiho Pharmaceutical; Yakult Honsha
Speakers' Bureau - Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Eisai (Inst); Merck Serono (Inst); MSD (Inst); NanoCarrier (Inst); Taiho Pharmaceutical (Inst); Zeria Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; Novartis; Pfizer; Taiho Pharmaceutical
 
Yasushi Omuro
Research Funding - Taiho Pharmaceutical
 
Taketo Yamaguchi
Research Funding - Taiho Pharmaceutical
 
Hiroki Hara
Honoraria - Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Chugai Pharma; Merck Serono; Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Kazuya Sugimori
Research Funding - Taiho Pharmaceutical
 
Junji Furuse
Honoraria - Astellas Pharma; AstraZeneca; Bayer Yakuhin; Chugai Pharma; Daiichi Sankyo; EA Pharma; Eisai; Lilly Japan; Merck Serono; Mitsubishi Tanabe Pharma; Mochida Pharmaceutical Co. Ltd.; MSD; Novartis; Ono Pharmaceutical; Pfizer; Sawai Pharmaceutical Co; Shionogi; Sumitomo Dainippon; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Eisai; Fujifilm; J-Pharma; Kyowa Hakko Kirin; Lilly Japan; MSD; Novartis; Novartis; Ono Pharmaceutical; Otsuka; Sandoz; Sanofi; Shionogi; Taiho Pharmaceutical; Yakult Pharmaceutical; Zeria Pharmaceutical
Speakers' Bureau - Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Astellas Pharma; Bayer; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; J-Pharma; Janssen; Kyowa Hakko Kirin; Lilly Japan; Merck Serono; Mochida Pharmaceutical Co. Ltd.; MSD; NanoCarrier; NanoCarrier; Novartis; OncoTherapy Science; Ono Pharmaceutical; Shionogi; Sumitomo Dainippon; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical; Zeria Pharmaceutical
 
Masahiro Takeuchi
Honoraria - Shionogi
Consulting or Advisory Role - Abbvie; Astellas Pharma; Hisamitsu Pharmaceutical; Taiho Pharmaceutical
 
Takuji Okusaka
Honoraria - AstraZeneca Japan; Baxter; Bayer Yakuhin; Celgene; Chugai Pharma; Dainippon Sumitomo Pharma; EA Pharma; Fujifilm; Lilly Japan; Merck Serono; Nippon Chemiphar; Nippon Kayaku; Nobelpharma; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Daiichi Sankyo; Dainippon Sumitomo Pharma; Lilly Japan; Nippon Boehringer Ingelheim; Taiho Pharmaceutical; Zeria Pharmaceutical
Research Funding - AstraZeneca Japan; Baxter; Bayer Yakuhin; Chugai Pharma; Dainippon Sumitomo Pharma; Eisai; GlaxoSmithKline K.K.; Kowa; Kyowa Hakko Kirin; Lilly Japan; Merck Serono; NanoCarrier; Nippon Boehringer Ingelheim; Nobelpharma; Novartis; Ono Pharmaceutical; Pfizer; Shizuoka Industry; Taiho Pharmaceutical; Yakult Honsha; Zeria Pharmaceutical
 
Narikazu Boku
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Ono Pharmaceutical; Shionogi; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Bristol-Myers Squibb (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Ichinosuke Hyodo
Honoraria - Chugai Pharma; Daiichi Sankyo; Lilly; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo